These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7150461)

  • 21. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure.
    Knauf H; Mutschler E
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):394-400. PubMed ID: 8583780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-dependent salidiuretic efficacy of torasemide in comparison to furosemide and placebo in advanced renal failure.
    Mourad G; Haecker W; Mion C
    Arzneimittelforschung; 1988 Jan; 38(1A):205-8. PubMed ID: 3285835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and pharmacokinetics of piretanide in patients with congestive heart failure.
    Marone C; Rivera B; Zwahlen H; Lahn W; Frey F
    Eur J Clin Invest; 1989 Aug; 19(4):378-83. PubMed ID: 2506054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
    Kult J; Häcker W; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetics and diuretic effects of piretanide in chronic renal insufficiency.
    Berg KJ; Walstad RA; Bergh K
    Br J Clin Pharmacol; 1983 Mar; 15(3):347-53. PubMed ID: 6342640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacology of loop diuretics: a comparative study.
    Ansuini R; Pulido M; Pupita G; Gaggi S; Pupita F
    Int J Clin Pharmacol Res; 1985; 5(2):113-21. PubMed ID: 4018941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.
    Gottlieb SS; Brater DC; Thomas I; Havranek E; Bourge R; Goldman S; Dyer F; Gomez M; Bennett D; Ticho B; Beckman E; Abraham WT
    Circulation; 2002 Mar; 105(11):1348-53. PubMed ID: 11901047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
    Arroyo V; Bosch J; Casamitjana R; Cabrera J; Rivera F; Rodés J
    Gut; 1980 Oct; 21(10):855-9. PubMed ID: 7439805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of loop diuretics, piretanide and frusemide, against sodium metabisulphite-induced bronchoconstriction in asthma.
    Yeo CT; O'Connor BJ; Chen-Worsdell M; Barnes PJ; Chung KF
    Eur Respir J; 1992 Nov; 5(10):1184-8. PubMed ID: 1486963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of frusemide in chronic renal failure.
    Keeton GR; Morrison S
    Nephron; 1981; 28(4):169-73. PubMed ID: 7301002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of the effect of dopamine on renal excretion in chronic renal failure (author's transl)].
    Baglin A; Goupil A; Domart M; Fritel D
    Nouv Presse Med; 1979 May; 8(22):1821-5. PubMed ID: 471742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of a single, intravenous dose of bumetanide versus furosemide in patients with ascites and edema due to alcoholic liver disease.
    Koff RS
    J Clin Pharmacol; 1981; 21(11):706-11. PubMed ID: 7040497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Open comparison of diuretic effects of piretanide and bumetanide in patients with stable renal transplants.
    Bailey RR
    N Z Med J; 1982 Jan; 95(700):44-5. PubMed ID: 7038567
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of intravenous piretanide and furosemide in patients with congestive heart failure.
    Marsh JD; Nesto R; Glynn MA; Smith TW
    J Cardiovasc Pharmacol; 1982; 4(6):949-54. PubMed ID: 6185787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of frusemide and piretanide on the renal clearance of gentamicin in man.
    Whiting PH; Barber HE; Petersen J
    Br J Clin Pharmacol; 1981 Dec; 12(6):795-9. PubMed ID: 7340881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure.
    Sherman LG; Liang CS; Baumgardner S; Charuzi Y; Chardo F; Kim CS
    Clin Pharmacol Ther; 1986 Nov; 40(5):587-94. PubMed ID: 3533372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Addition of indapamide to frusemide increases natriuresis and creatinine clearance, but not diuresis, in fluid overloaded ICU patients.
    Bihari S; Holt AW; Prakash S; Bersten AD
    J Crit Care; 2016 Jun; 33():200-6. PubMed ID: 26948252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and pathophysiological effects of piretanide treatment in the nephrotic syndrome.
    Plum J; Plum F; Pooth R; Grabensee B
    Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):400-6. PubMed ID: 1836204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bumetanide, a new diuretic.
    Hofstetter A
    Int Urol Nephrol; 1974; 6(1):35-42. PubMed ID: 4617729
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of the loop diuretic piretanide in renal failure.
    Walter U; Röckel A; Lahn W; Heidland A; Heptner W
    Eur J Clin Pharmacol; 1985; 29(3):337-43. PubMed ID: 4076330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.